• 1. Department of General Surgery, The Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai 201700, P. R. China;
  • 2. Endoscopy Center, The Qingpu Branch of Zhongshan Hospital Affiliated to Fudan University, Shanghai 201700, P. R. China;
  • 3. Weight Loss Center, The First Affiliated Hospital of Jinan University, Guangzhou 510630, P. R. China;
WANG Cunchuan, Email: twcc@jnu.edu.cn; PENG Zhiyong, Email: pw.bao.bao@163.com
Export PDF Favorites Scan Get Citation

Endoscopic bariatric treatment (EBT) is an effective method for the treatment of obesity. The principle of weight loss is similar to metabolic bariatric surgery. It can be classified as a food restriction (stomach-targeted) and malabsorption (small intestine-targeted). At present, a lot of EBT devices had been cleared by the US Food and Drug Administration to treat obesity, while the EBT in China lagged behind Western countries. Hence, we reviewed the current stomach-targeted EBT, aiming to provide a reference for the supplement of obesity treatment methods and the development of EBT in China.

Citation: BIAN Jingyuan, ZHU Baocheng, YAN Bin, WANG Cunchuan, PENG Zhiyong. Current status and future perspectives of stomach-targeted endoscopic bariatrics. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2024, 31(4): 403-408. doi: 10.7507/1007-9424.202403075 Copy

  • Previous Article

    Prospects and considerations of sleeve gastrectomy with transit bipartition
  • Next Article

    Staple-line reinforcement or not during laparoscopic sleeve gastrectomy: a historical cohort study